^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Hodgkin Lymphoma
    Regimen:DHAP
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Hodgkin Lymphoma: CHL, Second-line option added:...DHAP (dexamethasone, cisplatin, high-dose cytarabine).